Michael D. Blum

Real-World Evidence for Assessing Treatment Effectiveness and Safety in Pediatric Populations

M. Burcu, D. Horton, Michael D. Blum, 2021, The Journal of Pediatrics.

International Collaboration in Real‐World Evidence Generation for Direct Acting Oral Anti‐Coagulants

X. Kurz, P. Arlett, Michael D. Blum, 2020, Clinical pharmacology and therapeutics.

Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

Jan Bonhoeffer, Ulrich Heininger, M. Mäkelä, 2007, Vaccine.

Understanding utilization patterns of biologics and biosimilars in the United States to support postmarketing studies of safety and effectiveness

Jennifer G. Lyons, S. Toh, M. Nguyen, 2019, Pharmacoepidemiology and drug safety.

Real‐world evidence to support regulatory decision‐making for medicines: Considerations for external control arms

N. Dreyer, E. Perfetto, J. Franklin, 2020, Pharmacoepidemiology and drug safety.

Temafloxacin syndrome: review of 95 cases.

D J Graham, D. Graham, M D Blum, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic

Andrew A Leboeuf, G. D. Dal Pan, Melina Fanari, 2022, Drug Safety.